Shandong Buchang Pharmaceuticals' low P/S ratio may reflect ...
Shandong Buchang Pharmaceuticals' low P/S ratio may reflect expectations of continued disappointing revenue performance. The company's declining revenue and predicted industry growth could challenge its current P/S ratio, potentially disappointing shareholders. Current investor sentiment and future expectations do not seem to justify a higher P/S ratio for the company.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000290b150965418f.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment